10,367 Shares in HealthEquity, Inc. $HQY Purchased by State of Wyoming

State of Wyoming acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the first quarter, Holdings Channel reports. The firm acquired 10,367 shares of the company’s stock, valued at approximately $866,000.

Other large investors also recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC bought a new position in HealthEquity in the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd increased its position in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $28,000. Leonteq Securities AG raised its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Torren Management LLC purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $40,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

Shares of HQY stock opened at $95.95 on Thursday. The firm has a market cap of $8.02 billion, a price-to-earnings ratio of 35.94, a PEG ratio of 1.64 and a beta of 0.21. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The company’s 50 day moving average is $89.72 and its 200 day moving average is $84.85.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on HQY. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research note on Monday, June 1st. Royal Bank Of Canada upped their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Barrington Research restated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Finally, Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $110.57.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.